[40岁以后避孕]。

La Revue du praticien Pub Date : 2025-03-01
Marie Lambert
{"title":"[40岁以后避孕]。","authors":"Marie Lambert","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>CONTRACEPTION AFTER FORTY. The prescription of contraception after the age of 40 should be discussed with each woman because fertility and pregnancy's risk still exist. It requires a thorough evaluation of the situation, to identify any vascular and metabolic risk factors. No method of contraception is contraindicated by age alone. However, because age is a risk factor for vascular and metabolic diseases, combined hormonal contraception and injectable progestins should not be prescribed at first intention. Long-acting reversible contraception, sterilization and progestin-only pills have to be prescribed as first-line.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 3","pages":"276-278"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Contraception after forty].\",\"authors\":\"Marie Lambert\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>CONTRACEPTION AFTER FORTY. The prescription of contraception after the age of 40 should be discussed with each woman because fertility and pregnancy's risk still exist. It requires a thorough evaluation of the situation, to identify any vascular and metabolic risk factors. No method of contraception is contraindicated by age alone. However, because age is a risk factor for vascular and metabolic diseases, combined hormonal contraception and injectable progestins should not be prescribed at first intention. Long-acting reversible contraception, sterilization and progestin-only pills have to be prescribed as first-line.</p>\",\"PeriodicalId\":94123,\"journal\":{\"name\":\"La Revue du praticien\",\"volume\":\"75 3\",\"pages\":\"276-278\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"La Revue du praticien\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"La Revue du praticien","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

40岁以后避孕。40岁以后的避孕处方应与每位妇女讨论,因为生育和怀孕的风险仍然存在。它需要对情况进行彻底的评估,以确定任何血管和代谢风险因素。没有避孕方法是禁忌的年龄单独。然而,由于年龄是血管和代谢性疾病的危险因素,一开始不应开激素避孕和注射黄体酮的联合处方。长效可逆避孕、绝育和仅含黄体酮的药物必须作为一线处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Contraception after forty].

CONTRACEPTION AFTER FORTY. The prescription of contraception after the age of 40 should be discussed with each woman because fertility and pregnancy's risk still exist. It requires a thorough evaluation of the situation, to identify any vascular and metabolic risk factors. No method of contraception is contraindicated by age alone. However, because age is a risk factor for vascular and metabolic diseases, combined hormonal contraception and injectable progestins should not be prescribed at first intention. Long-acting reversible contraception, sterilization and progestin-only pills have to be prescribed as first-line.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信